IntegriChain Named a 2019 Best Place to Work by Philadelphia Business Journal
IntegriChainhas been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2019 in the large-sized company category.
News
IntegriChain Releases 10+ Groundbreaking Artificial Intelligence/Machine Learning Algorithms and Predictive Analytics for Life Sciences Access and Commercial Insights
IntegriChain has now implemented more than 10 artificial intelligence/machine learning (AI/ML) models and predictive analytics to its ICyte Platform. IntegriChain’s advancements in AI/ML and predictive analytics were recently highlighted in a Gartner report, “Life Science CIOs Can Accelerate Commercial Effectiveness With New Applications of Artificial Intelligence,” which is available on Gartner.com.
IntegriChain’s Josh Halpern to Present on Data-Driven Patient Services at CBI Patient Support Services Congress
Co-Founder and EVP, Product & Strategy Josh Halpern, will present “Leveraging Data Science to Improve Patient Adherence" at the CBI Patient Support Services Congress June 19.
IntegriChain’s Jen Sharpe to Present on GTN Best Practices at CBI Financial Strategies and Accounting for Bioscience Companies
Jen Sharpe, IntegriChain's Executive Advisor for the Revenue Analytics Collaborative, will present at the CBI Financial Strategies and Accounting for Bioscience Companies on “Ensuring Best Practices in GTN Accounting and Forecasting: Copay, Coverage Gap and Returns — Three Pain Points Resolved."
IntegriChain Opens Registration for its Access Insights Conference 2019
IntegriChain opens registration for the Access Insights Conference 2019, formerly known as the IntegriChain User Conference. The Access Insights Conference will be held October 21-23, 2019, in the Atlanta/Buckhead area.
IntegriChain and daVIZta Merge, Creating Best-in-Class Payer Data and Analytics Solutions for the Life Sciences Industry
IntegriChain merges with daVIZta, a leading provider of revenue analytics software, including gross-to-net (GTN) automation and government pricing solutions -- key challenges for commercial-stage life sciences companies to ensure access to new and existing therapies -- and serves as a trusted partner to large, mid-tier, and emerging life sciences manufacturers.
IntegriChain to Present at Baird’s 4th Annual Private Company Technology & Services Conference
IntegriChain’s Executive Vice President, Joshua Halpern, will present a company overview at Baird's 4th Annual Private Company Technology & Services Conference on Wednesday, February 13 in New York.
IntegriChain Launches Life Sciences Commercial Data Refinery for Specialty and Retail Bio/Pharma Brands
IntegriChain launches the Data Refinery for its Patient and Distribution solutions, capitalizing on fully automated metadata processes and advanced machine learning to deliver Data Enrichment 3.0, the next-generation of data enrichment, to improve the efficiency, consistency, accuracy, and adaptability of key commercial datasets for specialty and retail bio/pharma brands.
IntegriChain’s Josh Halpern to Present on Data-Driven Patient Services at CBI Trade & Channel 2018 Conference
Co-Founder and EVP, Product & Strategy, Josh Halpern, will present “Opportunities for Data-Driven Patient Services" at the CBI 2018 Trade & Channel Conference.
